NCT05885295 · RECRUITING

The Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3)

This study is testing a new digital cognitive assessment tool called IC3, designed specifically for stroke survivors. Researchers want to know whether it can reliably detect memory and thinking problems after stroke, and whether combining it with brain MRI and blood tests reveals useful markers of cognitive recovery. This is an observational study, not a drug trial — no experimental treatment is being given.

Eligibility criteria

Inclusion Criteria:
* Aged > 18
* Evidence of confirmed stroke (for patients)
* Ability to concentrate for 15 minutes at a time to engage with cognitive testing
Exclusion Criteria for the main study:
* Pre-stroke diagnosis of dementia
* Severe visuo-spatial problems, fatigue, or mental health problems
* Severe hearing impairment in the presence of reading comprehension impairment
Exclusion Criteria for the MRI imaging sub-study:
* Pregnancy
* Presence of metal implants
* Claustrophobia

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2023-06-01

View full record on ClinicalTrials.gov

All APOE4 clinical trials